ARCHIVES

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

This article is from The Cancer Letter archive.

Vol. 39 No. 17 | April 25, 2013

Download PDF Visit The Full Archive

Related Articles

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005